**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
|----------------|--------------------------------------|----------|-----------|
| 75-09-2 |Dichloromethane | 84 | 200-838-9 |
|----------------|--------------------------------------|----------|-----------|
| 7790-99-0 |Iodine monochloride | 16 | 232-236-7 |
+----------------+--------------------------------------+----------+-----------+
Text for R-phrases: see Section 16
Hazard Symbols: C
Risk Phrases: 34 40
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Causes burns. Limited evidence of a carcinogenic effect.
Potential Health Effects
Eye:
Causes eye burns. Contact with eyes may cause severe irritation,
and possible eye burns. Causes redness and pain.
Skin:
Causes skin burns. Causes redness and pain.
Ingestion:
Causes gastrointestinal irritation with nausea, vomiting and
diarrhea. Causes gastrointestinal tract burns. May cause central
nervous system depression, characterized by excitement, followed by
headache, dizziness, drowsiness, and nausea. Advanced stages may
cause collapse, unconsciousness, coma and possible death due to
respiratory failure.
Inhalation:
Inhalation of high concentrations may cause central nervous system
effects characterized by nausea, headache, dizziness, unconsciousness
and coma. Causes chemical burns to the respiratory tract. May cause
narcotic effects in high concentration. Vapors may cause dizziness or
suffocation. May cause thryoid effects. May cause blood changes.
Overexposure may cause an increase in carboxyhemoglobin levels in
the blood.
Chronic:
Possible cancer hazard based on tests with laboratory animals.
Prolonged or repeated skin contact may cause dermatitis. May cause
reproductive and fetal effects. Laboratory experiments have resulted
in mutagenic effects. Chronic exposure may cause lung, liver, and
pancreatic tumors. Chronic exposure may cause kidney damage.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Immediately flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid
immediately.
Skin:
Get medical aid immediately. Immediately flush skin with plenty of
water for at least 15 minutes while removing contaminated clothing
and shoes.
Ingestion:
Do not induce vomiting. If victim is conscious and alert, give 2-4
cupfuls of milk or water. Never give anything by mouth to an
unconscious person. Get medical aid immediately.
Inhalation:
Get medical aid immediately. Remove from exposure and move to fresh
air immediately. If not breathing, give artificial respiration. If
breathing is difficult, give oxygen. Do NOT use mouth-to-mouth
resuscitation. If breathing has ceased apply artificial respiration
using oxygen and a suitable mechanical device such as a bag and a
mask.
Notes to Physician:
Treat symptomatically and supportively.
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. Use water spray to keep fire-exposed containers
cool. Vapors mixed with air in proper proportion will propagate a
flame. Vapors may be heavier than air. They can spread along the
ground and collect in low or confined areas. Containers may explode
when heated. Will form explosive mixtures in atmospheres having high
oxygen contents. Non-combustible, substance itself does not burn but
may decompose upon heating to produce corrosive and/or toxic fumes.
Extinguishing Media:
Do NOT use water directly on fire. Use foam, dry chemical, or carbon
dioxide. Cool containers with flooding quantities of water until well
after fire is out.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth),
then place in suitable container. Avoid runoff into storm sewers and
ditches which lead to waterways. Remove all sources of ignition. Use
a spark-proof tool. Provide ventilation.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Loosen closure cautiously before opening. Do not breathe dust,
vapor, mist, or gas. Do not get in eyes, on skin, or on clothing.
Take precautionary measures against static discharges. Keep away from
heat, sparks and flame. Do not ingest or inhale. Use only in a
chemical fume hood.
Storage:
Keep away from heat, sparks, and flame. Store in a cool, dry place.
Store in a tightly closed container. Keep from contact with
oxidizing materials. Corrosives area.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate
ventilation to keep airborne concentrations low.
Exposure Limits
CAS# 75-09-2:
United Kingdom, WEL - TWA: 100 ppm TWA; 350 mg/m3 TWA
United Kingdom, WEL - STEL: 300 ppm STEL; 1060 mg/m3 STEL
United States OSHA: ; 25 ppm TWA (8 hr); 125 ppm STEL (15 min); 1
ppm Action Level (See 29 CFR 1910 .1052)
Belgium - TWA: 50 ppm VLE; 177 mg/m3 VLE
France - VME: 50 ppm VME; 180 mg/m3 VME
France - VLE: 100 ppm VLE; 350 mg/m3 VLE
Germany: 100 ppm TWA; 350 mg/m3 TWA
Japan: 50 ppm OEL; 170 mg/m3 OEL
Japan: 100 ppm Ceiling; 340 mg/m3 Ceiling
Malaysia: 50 ppm TWA
Netherlands: 500 ppm STEL; 1750 mg/m3 STEL
Netherlands: 100 ppm MAC; 350 mg/m3 MAC
Russia: 50 mg/m3 TWA
Spain: 50 ppm VLA-ED; 177 mg/m3 VLA-ED
CAS# 7790-99-0:
Personal Protective Equipment
Eyes:
Not available.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
Follow the OSHA respirator regulations found in 29
CFR 1910.134 or European Standard EN 149. Use a
NIOSH/MSHA or European Standard EN 149 approved
respirator if exposure limits are exceeded or if
irritation or other symptoms are experienced.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Liquid
Color: orange-brown
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: Not available.
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density: 1.420
Molecular Formula: ClI
Molecular Weight: 162.35
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable at room temperature in closed containers under normal storage
and handling conditions.
Conditions to Avoid:
Incompatible materials, ignition sources.
Incompatibilities with Other Materials:
Metals, active metals, finely powdered metals, liquid oxygen,
magnesium, potassium, sodium, lithium, dinitrogen tetraoxide,
potassium-tert-butoxide, sodium potassium alloys, alkali metals,
aluminum, amines, perchloric acid, alcohols, alkaline earth metals,
aluminum bromide, azides, dimethyl sulfoxide, dinitrogen pentaoxide,
dinitrogen + tetraoxide, oxidizing agents, plastics, rubber,
coatings, iron, steel, copper, nickel, strong acids, nitric acid.
Hazardous Decomposition Products:
Hydrogen chloride, phosgene, carbon monoxide, carbon dioxide,
hydrogen iodide.
Hazardous Polymerization: Will not occur.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 75-09-2: PA8050000
CAS# 7790-99-0: NN1650000
LD50/LC50:
CAS# 75-09-2: Draize test, rabbit, eye: 162 mg Moderate; Draize
test, rabbit, eye: 10 mg Mild; Draize test, rabbit, eye: 500 mg/24H
Mild; Draize test, rabbit, skin: 810 mg/24H Severe; Draize test,
rabbit, skin: 100 mg/24H Moderate; Inhalation, mouse: LC50 = 14400
ppm/7H; Inhalation, mouse: LC50 = 49100 mg/m3/6H; Inhalation, mouse:
LC50 = 54000 mg/m3/2H; Inhalation, mouse: LC50 = 56220 mg/m3/7H;
Inhalation, rat: LC50 = 52 gm/m3; Inhalation, rat: LC50 = 76000
mg/m3/4H; Inhalation, rat: LC50 = 52000 mg/m3/6H; Oral, mouse: LD50
= 873 mg/kg; Oral, rabbit: LD50 = 2000 mg/kg; Oral, rat: LD50 = 1600
mg/kg; Oral, rat: LD50 = 985 mg/kg.
CAS# 7790-99-0.
Carcinogenicity:
Dichloromethane -
ACGIH: A3 - Confirmed animal carcinogen with unknown relevance to
California: carcinogen, initial date 4/1/88
NTP: Suspect carcinogen
IARC: Group 2B carcinogen
Iodine monochloride -
Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
Ecotoxicity:
logPOW: 1.25
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Shipping Name: CORROSIVE LIQUID, TOXIC, N.O.S.*
Hazard Class: 8 (6.1)
UN Number: 2922
Packing Group: III
IMO
Shipping Name: CORROSIVE LIQUID, TOXIC, N.O.S.
Hazard Class: 8 (6.1)
UN Number: 2922
Packing Group: III
RID/ADR
Shipping Name: CORROSIVE LIQUID, TOXIC, N.O.S.
Hazard Class: 8
UN Number: 2922
Packing group: III
USA RQ: CAS# 75-09-2: 1000 lb final RQ; 454 kg final RQ
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: C
Risk Phrases:
R 34 Causes burns.
R 40 Limited evidence of a carcinogenic effect.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 36/37/39 Wear suitable protective clothing, gloves
and eye/face protection.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 75-09-2: 2
CAS# 7790-99-0: 1
Canada
CAS# 75-09-2 is listed on Canada's DSL List.
CAS# 7790-99-0 is listed on Canada's DSL List.
CAS# 75-09-2 is listed on Canada's Ingredient Disclosure List.
CAS# 7790-99-0 is listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 75-09-2 is listed on the TSCA inventory.
CAS# 7790-99-0 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
Text for R-phrases from Section 2
R 40 Limited evidence of a carcinogenic effect.
MSDS Creation Date: 6/10/2003 Revision #0 Date: Original.
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|